RFL Stock Overview
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Rafael Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.90 |
| 52 Week High | US$2.50 |
| 52 Week Low | US$1.29 |
| Beta | 1.15 |
| 1 Month Change | -5.47% |
| 3 Month Change | -1.04% |
| 1 Year Change | 11.11% |
| 3 Year Change | -23.39% |
| 5 Year Change | -83.55% |
| Change since IPO | -61.22% |
Recent News & Updates
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?
Oct 11
Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)
Mar 21Recent updates
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet?
Oct 11Solid Earnings May Not Tell The Whole Story For Rafael Holdings (NYSE:RFL)
Mar 21We Think Rafael Holdings (NYSE:RFL) Needs To Drive Business Growth Carefully
Aug 04Rafael Holdings GAAP EPS of -$0.22
Dec 13Rafael stepping back from early-stage development in favor of acquisition, licensing
Nov 16Is Rafael Holdings (NYSE:RFL) Using Debt In A Risky Way?
Jan 20Rafael Holdings: A Coin Flip
Nov 18Rafael Holdings announces merger with Rafael Pharmaceuticals
Jun 21Rafael Holdings adds three new members to board
Jun 14What You Need To Know About Rafael Holdings, Inc.'s (NYSE:RFL) Investor Composition
Jan 25
Rafael Holdings reports FQ1 results
Dec 15The Rafael Holdings (NYSE:RFL) Share Price Has Gained 29% And Shareholders Are Hoping For More
Dec 01Shareholder Returns
| RFL | US Real Estate | US Market | |
|---|---|---|---|
| 7D | -6.9% | 1.0% | -1.9% |
| 1Y | 11.1% | 28.1% | 14.0% |
Return vs Industry: RFL underperformed the US Real Estate industry which returned 28.1% over the past year.
Return vs Market: RFL underperformed the US Market which returned 14% over the past year.
Price Volatility
| RFL volatility | |
|---|---|
| RFL Average Weekly Movement | 8.4% |
| Real Estate Industry Average Movement | 6.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: RFL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RFL's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 30 | Bill Conkling | www.rafaelholdings.com |
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Rafael Holdings, Inc. Fundamentals Summary
| RFL fundamental statistics | |
|---|---|
| Market cap | US$46.39m |
| Earnings (TTM) | -US$39.78m |
| Revenue (TTM) | US$697.00k |
67.3x
P/S Ratio-1.2x
P/E RatioIs RFL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RFL income statement (TTM) | |
|---|---|
| Revenue | US$697.00k |
| Cost of Revenue | US$191.00k |
| Gross Profit | US$506.00k |
| Other Expenses | US$40.28m |
| Earnings | -US$39.78m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.61 |
| Gross Margin | 72.60% |
| Net Profit Margin | -5,707.03% |
| Debt/Equity Ratio | 3.1% |
How did RFL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/06 00:13 |
| End of Day Share Price | 2025/03/06 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Rafael Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.